Donate Today
Skip to Content

Progress Against Cancer

Home Patients, Caregivers, and Advocates Progress Against Cancer Research Page 2

Recent Progress: FDA Approvals

Drugging an “Undruggable” Protein 

Drugging an “Undruggable” Protein 

A second inhibitor of the difficult-to-target KRAS protein was approved to treat certain lung cancers.  The U.S. Food and Drug Administration (FDA) has granted accelerated approval to adagrasib (Krazati) for adult patients with locally...